The stock market is taking a breather after a relentless run, but opportunities still abound, according to some on Wall ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

(NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor ...

Cantor Fitzgerald analyst Kristen Kluska tells investors that shares of Celldex (CLDX) have declined 28% over the last six months primarily ...

Cantor Fitzgerald has recently raised Cameco Corp (CCJ) stock to Overweight rating, as announced on July 31, 2024, according to Finviz. Earlier, on April 1, 2024, Goldman had initiated the stock to ...

Cantor Fitzgerald restated their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Ouster Inc (OUST) stock saw a modest uptick, ending the day at $14.64 which represents a slight increase of $2.29 or 18.54% from the prior close of $12.35. The stock opened at $12.4 and touched a low ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares after the company announced results from the Phase 3 ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

Weakness in Cantor Fitzgerald High Income A's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative. Our research team assigns Negative ratings to ...

BGC Group stock rose 1.6% in premarket trading after reaffirming Q4 revenue and earnings guidance, expecting growth in both metrics.